申请人:Bayer Aktiengesellschaft
公开号:US05272161A1
公开(公告)日:1993-12-21
Indolesulphonamide-substituted dihydropyridines can be prepared by reaction of dihydropyridinecarboxylic acids with hydroxy-substituted indolesulphonamides, or by reaction of amino- or hydroxy-substituted dihydropyridines with indolesulphonamidecarboxylic acids. The indolesulphonamide-substituted dihydropyridines can be employed as active substances in medicaments for the treatment of cardiac, circulatory and thromboedabolic disorders.
印度
吲哚磺酰胺取代的
二氢吡啶可以通过
二氢吡啶羧酸与羟基取代的
吲哚磺酰胺反应或
氨基或羟基取代的
二氢吡啶与
吲哚磺酰胺
羧酸反应制备。印度
吲哚磺酰胺取代的
二氢吡啶可用作治疗心脏、循环和血栓病的药物中的活性物质。